...
首页> 外文期刊>Acta neurochirurgica.Supplement >The role of Gamma Knife radiosurgery in the management of glomus jugular tumours.
【24h】

The role of Gamma Knife radiosurgery in the management of glomus jugular tumours.

机译:伽玛刀放射外科在控制球状颈静脉瘤中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Glomus jugular tumours are usually managed by microsurgical resection and/or radiotherapy with considerable risk for treatment-related morbidity. The role of Gamma Knife Radiosurgery (GKRS) in the management of these lesions remains to be defined. METHOD: Between May 1992 and November 2000, 19 patients with glomus tumours underwent GKRS at our department. Nine patients received radiosurgery for residual or recurrent paragangliomas following microsurgical resection and in 10 cases GKRS was performed as primary treatment. The median tumour volume was 5.22 ccm (range: 0.38-33.5 ccm). Marginal doses of 12-20 Gy (median 14 Gy) were applied to enveloping isodose volume curves (Range: 30-55%, median 50%). FINDINGS: Except for an 81-year-old patient who died 9 months after radiosurgery the observation time ranged from 1.5 to 10 years (median 7.2 yrs). The total tumour control rate was 94.7% (7 cases with decreased and 11 with stable tumour size). The only patient with tumour progression (5.3%) underwent repeated radiosurgical treatment 85 months after initial GKRS. A newly diagnosed second lesion in the cavernous sinus was treated radiosurgically as well 53 months after the first Gamma Knife procedure. On clinical examination 10 patients (52.6%) presented with improved and 8 patients (42.1%) with unchanged neurological status. Deterioration in one patient (5.3%) was not related to tumour or radiosurgery. INTERPRETATION: As GKRS demonstrated to be a minimally invasive treatment alternative to microsurgery and radiotherapy with no acute or chronic toxicity it should be considered more frequently in the primary or adjuvant strategy for glomus jugular tumours.
机译:背景:球状颈静脉瘤通常通过显微手术切除和/或放疗来治疗,与治疗相关的发病风险相当大。伽玛刀放射外科(GKRS)在这些病变管理中的作用尚待确定。方法:在1992年5月至2000年11月之间,我科对19例球蛋白瘤患者进行了GKRS治疗。 9名患者接受了显微手术切除后残余或复发性副神经节瘤的放射外科手术,其中10例以GKRS作为主要治疗方法。中位肿瘤体积为5.22 ccm(范围:0.38-33.5 ccm)。将12-20 Gy的边际剂量(中位数14 Gy)应用于包络的等剂量体积曲线(范围:30-55%,中位数50%)。结果:除了一名81岁的患者在放射外科手术后9个月死亡外,观察时间为1.5到10年(中值7.2岁)。总体肿瘤控制率为94.7%(肿瘤缩小7例,肿瘤大小稳定11例)。初始GKRS术后85个月,仅有肿瘤进展的患者(5.3%)接受了重复放射外科治疗。第一次伽玛刀手术后53个月,对放射诊断的海绵窦中的第二个病变进行了放射外科治疗。在临床检查中,有10例患者(52.6%)表现出改善,而8例患者(42.1%)表现出神经状态不变。一名患者(5.3%)的恶化与肿瘤或放射外科手术无关。解释:由于GKRS被证明是显微外科手术和放射疗法的微创治疗方法,无急性或慢性毒性,因此在球状颈静脉肿瘤的主要或辅助治疗策略中应更频繁地考虑使用GKRS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号